This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Insulin Infusion in the Hospital Wards

This study has been completed.
Information provided by (Responsible Party):
Guillermo Umpierrez, Emory University Identifier:
First received: December 14, 2006
Last updated: February 7, 2014
Last verified: February 2014

Increasing evidence from clinical studies in Intensive Care Unit (ICU) settings indicates that insulin infusion can improve outcome measures for patients with hyperglycemia (high blood sugar) independent of a previous diagnosis of diabetes mellitus. This improvement in health could also apply to patients that have high blood sugars in various other non-critical care areas of the hospital as well. However, the data that shows improvement in health outcomes has been collected from wards that have a lower patient to provider and patient to nurse ratio, resulting in the ability for a much tighter control of the insulin infusion. We hypothesize that tight blood glucose control will provide the same benefits for patients in non-intensive care units settings but that these protocols may lead to a higher incidence of hypoglycemia (low blood sugar) and potentially to adverse outcomes in patients.

This study aims to determine the clinical outcome of patients treated with insulin infusion as well as the rate of hypoglycemic episodes in non-intensive areas. We will conduct a chart review of patients treated with insulin infusions in non-critical wards at Emory University Hospital during the period of 7/1/04 to 6/30/05. Medical records of all patients treated with intravenous insulin infusion protocols will be analyzed. Data on demographics, laboratory values, mortality rate, rate of hypoglycemic events, length of stay, as well as disposition at discharge will be analyzed.

Condition Intervention
Hyperglycemia Drug: Insulin Drip Therapy

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Insulin Infusion and Outcomes for Non-Critical Wards

Resource links provided by NLM:

Further study details as provided by Guillermo Umpierrez, Emory University:

Enrollment: 200
Study Start Date: August 2006
Estimated Study Completion Date: December 2006

Ages Eligible for Study:   19 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Cohort of hospitalized adult subjects in a teaching institution.

Inclusion Criteria:

  • All subjects over 18 years of age that received intravenous insulin treatment on general medical and surgical wards at Emory University Hospital during the period of 7/1/2004 to 6/30/2005
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00412347

United States, Georgia
University Hospital
Atlanta, Georgia, United States, 30324
Sponsors and Collaborators
Emory University
Principal Investigator: Guillermo Umpierrez, MD Emory University
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Guillermo Umpierrez, Principal Investigator, Emory University Identifier: NCT00412347     History of Changes
Other Study ID Numbers: 1203-2005
1203-2005 ( Other Identifier: Other )
Study First Received: December 14, 2006
Last Updated: February 7, 2014

Keywords provided by Guillermo Umpierrez, Emory University:
insulin drip
general wards

Additional relevant MeSH terms:
Glucose Metabolism Disorders
Metabolic Diseases
Insulin, Globin Zinc
Hypoglycemic Agents
Physiological Effects of Drugs processed this record on September 21, 2017